Morgan Lewis

Morgan Lewis's Life Sciences Practice Recognized in PLCCross-border Life Sciences Handbook

Search Morgan Lewis News

search the archives

release date:
840 Stories Found

Related Publications

02/08/12 ERISA Service Provider and Enhanced Participant Disclosures: Near-Term Requirements and Long-Term Consequences—408(b)(2) Final Regulations Released
(pdf)
02/08/12 Final DOL 408(b)(2) Disclosure Regulation
Final regulation provides a number of helpful clarifications and changes, but continues to impose what will be a highly burdensome disclosure framework.
02/08/12 Managing Regulatory Impact on Generators, presented at the Generation Summit 2012, San Antonio, TX

Firm Fast Facts

Some 1,300 lawyers as well as patent agents, employee benefits advisors, regulatory scientists, and other specialists—nearly 3,000 professionals total—serve clients from our 22 offices throughout the world.

Clients include more than half of the Fortune 100 companies, including 9 of the top 10 and 16 of the top 20.

More than 2,000 clients have been with the firm for more than 5 years.

Approximately 2,000 new clients and 20,000 new projects each year.

Lawyers and support staff fluent in Arabic, Chinese (Mandarin), Dutch, English, French, German, Greek, Hebrew, Hindi, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Turkish.

  • date:

    12/20/2006
print news

The Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the PLCCross-border Life Sciences Handbook 2006/07, the most comprehensive rating publication covering law firms worldwide serving the life sciences industry.

The firm appears in six of the nine U.S. practice areas included this year—we were Highly Recommended in four areas: Regulatory (in both the United States and England), Regulatory-Medical Devices, Commercial and Partnering, and Competition/Antitrust; and we were Recommended in two areas: Corporate (in both the United States and Japan) and Government Enforcement and Investigations. The following seven Morgan Lewis attorneys are also named in the handbook:

  • Manya S. Deehr-Commercial and Partnering: Recognized in the United States
  • John C. Dodds-Government Enforcement and Investigations: Recommended in the United States
  • Kathryn L. Gleason-Regulatory: Recommended in the United States; Regulatory-Medical Devices: Highly Recommended in the United States
  • Stephen Paul Mahinka-Regulatory: Recommended in the United States; Competition/Antitrust: Highly Recommended in the United States
  • Kathleen M. Sanzo-Regulatory: Recommended in the United States; Government Enforcement and Investigations: Recommended in the United States
  • Randall B. Sunberg-Commercial and Partnering: Recommended in the United States
  • Anthony Warnock-Smith-Regulatory: Highly Recommended in England

To view the handbook online, please visit: http://crossborder.practicallaw.com/6-204-0360

In addition, Kathy Sanzo, Steve Mahinka, and Patrick L. Gilmore contributed an article for the Handbook titled "Overview of Healthcare Fraud Investigations in the U.S." The article discusses the rising trend of healthcare fraud and abuse investigations and focuses on various topics, including the reasons behind the increasing importance of healthcare fraud, who investigates healthcare fraud, and what activities lead to healthcare fraud investigations.

To view the entire article, please visit: http://www.morganlewis.com/pubs/PLCLifeSciences_OverviewHealthcare_2006-07.pdf





Related Attorneys:
Kathryn L. Gleason, Randall B. Sunberg, Anthony Warnock-Smith, John C. Dodds, Manya S. Deehr, Kathleen M. Sanzo, Stephen P. Mahinka